Pharma Times article: Narrowing the provision
Supplementary Protection Certificates are intended to ensure that medicinal products requiring marketing authorisation are adequately protected.
SEARCH
Showing 954 Results
Saiful Khan recognised as one of the world’s top IP value creators by IAM Strategy 300: The World's Leading IP Strategists 2019
We are delighted to announce that Saiful Khan has been recommended by IAM Strategy 300: The World’s Leading IP Strategists 2019.
Potter Clarkson recommended by IAM Patent 1000 - The World's Leading Patent Professionals 2019
Potter Clarkson is pleased to feature in IAM Patent 1000: The World's Leading Patent Professionals 2019 – a unique guide that identifies the top patent professionals in key jurisdictions around the globe.
Intellectual property risks and strategy for the Belt and Road initiative
Chinese businesses face challenges in ensuring their competitiveness when operating in foreign markets throughout the Belt and Road Initiative. Intellectual property can be key to overcoming these challenges and realising a business’s full potential.
Will “third party SPCs” in Europe be a thing of the past?
Under the SPC Regulation (No 469/2009), the holder of a basic patent is entitled to an SPC if the patent covers a product that has received a marketing authorisation (MA).
Patent applications on the rise
The European Patent Office and the World Intellectual Property Organization have both recently published patent filing figures for 2018.